UNSPSC 51282104: Carumonam

This classification denotes a beta-lactam antibiotic with the molecular formula C12H14N6O10S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 486890PI06 chemically known as acetic acid, (((2-((2-(((aminocarbonyl)oxy)methyl)-4-oxo-1-sulfo-3-azetidinyl)amino)-1-(2-amino-4-thiazolyl)-2-oxoethylidene)amino)oxy)-, (2s-(2.alpha.,3.alpha.(z)))- but generally known as carumonam, which bears US NIH Compound Identifier 9576417.

UNSPSC 51282104 Carumonam is a Commodity code under which state and local governments procure pharmaceutical products and medical supplies, though recent solicitations show minimal activity directly aligned with this specific drug identifier and instead reflect broader pharmaceutical and medical supply procurement across multiple product categories and delivery models. The solicitations under this code span naloxone and drug deactivation systems for community health programs, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing alliances, medical and first aid supplies for emergency response, and exploratory procurement for direct-to-manufacturer prescription programs. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), cities and municipal fire departments (City of Tampa), and multistate cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across multiple jurisdictions including Oregon).

Recent activity concentrates in Florida, Texas, and the upper Midwest through Minnesota's MMCAP. Representative solicitations include Seminole County's IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building; the City of Tampa's ITB 26P00145 (posted March 25, 2026; due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 and a Small Local Business Enterprise set-aside with a 5 percent bid discount; and Minnesota's MMCAP RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be supplied through three authorized wholesalers with a two-year contract term. The Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026) represents exploratory procurement activity for direct-to-manufacturer prescription programs but does not indicate immediate contracting intent or budget allocation.